Details for New Drug Application (NDA): 012429
✉ Email this page to a colleague
NDA 012429 describes THIOGUANINE, which is a drug marketed by Waylis Therap and is included in one NDA. It is available from one supplier. Additional details are available on the THIOGUANINE profile page.
The generic ingredient in THIOGUANINE is thioguanine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the thioguanine profile page.
The generic ingredient in THIOGUANINE is thioguanine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the thioguanine profile page.
Summary for 012429
| Tradename: | THIOGUANINE |
| Applicant: | Waylis Therap |
| Ingredient: | thioguanine |
| Patents: | 0 |
Suppliers and Packaging for NDA: 012429
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| THIOGUANINE | thioguanine | TABLET;ORAL | 012429 | NDA | Waylis Therapeutics LLC | 80725-630 | 80725-630-25 | 1 BOTTLE in 1 CARTON (80725-630-25) / 25 TABLET in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
